EVOGLIDE)

South Korea

NVENTRIC is a specialized medical device R&D company dedicated to vascular intervention, founded by industry veterans with over 20 years of expertise at global medtech leaders such as Johnson & Johnson and Abbott. We maintain a comprehensive portfolio across neurovascular, cardiovascular, and cardiac electrophysiology (EP) sectors. Building on our deep-rooted industry experience, we have recently initiated our global market expansion, catalyzed by the successful regulatory clearance of our neurovascular product line. A key highlight of our innovation is our proprietary technology in Pulsed Field Ablation (PFA), the next-generation gold standard for cardiac ablation. NVENTRIC’s technical excellence in PFA has gained international recognition, leading to a steady stream of strategic collaboration and co-development requests from major global corporations. By integrating proven field expertise with disruptive R&D, NVENTRIC is committed to solving clinical challenges and setting new global standards in the vascular medical device industry.